Poster Abstract Session:
165. Pneumococcal Immunization and Epidemiology-North America
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Estimating the Clinical and Economic Impact of Maintaining use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in Mexico
Matt Wasserman, MSc; Michele Wilson, MSPH; Cheryl McDade, BA; Ana Gabriela Grajales, MD; Maria Gabriela Palacios, MD; Fabiola Berenice Baez- Revueltas, PhD; Raymond Farkouh, PhD
Invasive pneumococcal disease in a population with underlying comorbidities
Daniel Jarovsky, MD; Eitan Naaman Berezin, MD; Rodrigo José Sini De Almeida, MD
  • Pôster IDWeek 2017.pdf (2.0 MB)
  • Pneumococcal vaccination provides substantial value for money for Canadians
    Francois Peloquin, BSc; Marie-Claude Breton, MPharm; Matt Wasserman, MSc; Michele Wilson, MSPH; Cheryl McDade, BA; Raymond Farkouh, PhD
    The Risk of Febrile Seizures Following Influenza and 13-Valent Pneumococcal Conjugate Vaccines  
    Meghan Baker, MD, ScD; Christopher Jankosky, MD, MPH; Katherine Yih, PhD, MPH; Susan Gruber, PhD; Lingling Li, PhD; Noelle Cocoros, DSc, MPH; Hana Lipowicz, MPH; Claudia Coronel-Moreno, MPH; Sandra Feibelmann, MPH; Nancy Lin, ScD; Cheryl McMahill-Walraven, PhD, MSW; David Menschik, MD, MPH; Mano Selvan, PhD; Nandini Selvam, PhD, MPH; Rong Chen Tilney, MS; Lauren Zichittella, MS; Grace Lee, MD, MPH, FPIDS; Alison Tse Kawai, ScD, SM
  • Baker_ID Week Poster.pdf (440.8 kB)
  • Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    Philippe De Wals, MD, PhD; Brigitte Lefebvre, PhD; Geneviève Deceunicnk, MSc; Jean Longtin, MD
  • IDWEEK 3x6feet= 92x180cm.pdf (436.0 kB)
  • Antibiotic Prescription Rates In Children <24 Months Old Following PCV7/PCV13 Sequential Implementation
    Ron Dagan, MD; Dana Danino, MD; Shalom Ben-Shimol, MD; David Greenberg, MD; Amir Sharf, MAEcon; Noga Givon-Lavi, PhD
    Yearly Trends of Antimicrobial Non-susceptibility among Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients in the United States (2009-2015)
    Rodrigo E. Mendes, Ph.D.; Heather L. Sings, PhD; Jose A. Suaya, MD, PhD; Leah N. Woosley, B.S.; Robert K. Flamm, PhD; Raúl E. Isturiz, MD
    Changing Epidemiology of Invasive Pneumococcal Disease due to Conjugate Vaccine Serotypes in Toronto, Canada After Introduction of a Routine Pediatric PCV13 Program.
    Allison Mcgeer, MD, MSc; Karen Green, MSc, RN; Agron Plevneshi, BSc; Wallis Rudnick, MSc.; Sylvia Pong-Porter, MLT; Jeff Li, BSc; Shalini Desai, MD
  • ID Week Poster 2017 - IPD.pdf (382.2 kB)
  • Impact of PCV13 on Serotype 3 invasive pneumococcal disease and nasopharyngeal carriage in Massachusetts’ children
    Rotem Lapidot, MD; Kimberly M. Shea, PhD, MPH; Brent A. Little, PhD; Inci Yildirim, MD, MSc; Stephen I. Pelton, MD
  • Poster ST3 IPD ID week .pdf (542.3 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.